Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

BACKGROUND: Aboriginal children living in Australian remote communities are at high risk of early and persistent otitis media, hearing loss, and social disadvantage. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are the primary pathogens. We compared otitis media outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Leach, Amanda Jane, Mulholland, Edward Kim, Santosham, Mathuram, Torzillo, Paul John, McIntyre, Peter, Smith-Vaughan, Heidi, Wilson, Nicole, Arrowsmith, Beth, Beissbarth, Jemima, Chatfield, Mark D., Oguoma, Victor M., Morris, Peter Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938290/
https://www.ncbi.nlm.nih.gov/pubmed/33685411
http://dx.doi.org/10.1186/s12887-021-02552-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938290/
https://www.ncbi.nlm.nih.gov/pubmed/33685411
http://dx.doi.org/10.1186/s12887-021-02552-z

Ejemplares similares